Inspiration from cruzioseptin-1: membranolytic analogue with improved antibacterial properties

Peptide engineering has gained attraction as a source of new cationicity-enhanced analogues with high potential for the design of next-generation antibiotics. In this context, cruzioseptin-1 (CZS-1), a peptide identified from Cruziohyla calcarifer, is recognized for its antimicrobial potency. Howeve...

ver descrição completa

Detalhes bibliográficos
Autores: Bermúdez Puga, Sebastián Armando, Morán Marcillo, Giovanna, Espinosa de Los Monteros Silva, Nina, Naranjo, Renato E, Toscano, Fernanda, Vizuete, Karla, de Almeida, José R, Proaño Bolaños, Carolina, Torres Arias, Marbel
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2023
País:Ecuador
Recursos:Universidad Regional Amazónica
Repositorio:Repositorio Universidad Regional Amazónica
OAI Identifier:oai:repositorio.ikiam.edu.ec:RD_IKIAM/646
Acesso em linha:https://doi.org/10.1007/s00726-022-03209-6
http://repositorio.ikiam.edu.ec/jspui/handle/RD_IKIAM/646
Access Level:acceso abierto
Palavra-chave:Antimicrobial peptides
Cruzioseptin.
Membranolytic effect
Rational design
Descrição
Resumo:Peptide engineering has gained attraction as a source of new cationicity-enhanced analogues with high potential for the design of next-generation antibiotics. In this context, cruzioseptin-1 (CZS-1), a peptide identified from Cruziohyla calcarifer, is recognized for its antimicrobial potency. However, this amidated-peptide is moderately hemolytic. In order to reduce toxicity and increase antimicrobial potency, 3 peptide analogues based on cruzioseptin-1 were designed and evaluated. [K4K15]CZS-1, an analogue with increased cationicity and reduced hydrophobicity, showed antibacterial, antifungal and antiproliferative properties. In addition, [K4K15]CZS-1 is less hemolytic than CZS-1. The in silico and scanning electron microscopy analysis reveal that [K4K15]CZS-1 induces a membranolytic effect on bacteria. Overall, these results confirm the potential of CZS-1 as source of inspiration for design new selective antimicrobial analogues useful for development of new therapeutic agents.